CymaBay Therapeutics Inc (NASDAQ:CBAY)

5.81
Delayed Data
As of Aug 22
 -0.12 / -2.02%
Today’s Change
4.82
Today|||52-Week Range
14.00
-26.18%
Year-to-Date

Today’s Trading

Previous close5.93
Today’s open5.95
Day’s range5.80 - 5.98
Volume246,352
Average volume (3 months)1,109,910
Market cap$399.8M
Data as of 4:00pm ET, 08/22/2019

Growth & Valuation

Earnings growth (last year)-58.86%
Earnings growth (this year)-17.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...0.000.00%
NUSNU Skin Enterprises ...+0.36+0.89%
HLFHerbalife Nutrition ...+0.79+2.26%
CAHCardinal Health Inc+0.19+0.44%
Data as of 6:30pm ET, 08/22/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$72.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sujal Shah
Chief Scientific Officer &
Senior Vice President
Charles A. McWherter
Corporate headquarters
Newark, California

Forecasts